OvaCis® is a globally patented Point-Of-Care device that discriminates benign from malignant epithelial Ovarian Cancer in 15 minutes.

As many as 1 in 10 women is likely to have an ovarian cyst in their lifetime

An ovarian cyst happens when fluid accumulates within a thin membrane inside the ovary. Ovarian cysts are frequently found incidentally in asymptomatic women and may sometimes be found in the course of evaluating women for pelvic pain.

5%-10% women with ovarian cysts will have surgery, of which 13%-21% of women that undergo intra-operative evaluation are found to have cancer. During the intra-operative evaluation, a procedure called Frozen Section is performed by slicing and preparing a section of freeze-dried ovarian tissue for microscopic examination. However, this procedure is not universally available, takes up to 60 minutes, with low accuracy.

  1. Holzer, R.A., Persons, R.K. and Jamieson, B., 2011. Evaluation of ovarian cysts.

INEX's Solution

OvaCis®, an intra-operative point of care’s medical device to determine if the ovarian cyst is benign or malignant within 15 minutes.

Step 1

Obtain cyst fluid

OvaCis® Rapid Test is for the intraoperative detection of epithelial ovarian cancer (EOC) based on the presence of haptoglobin in human ovarian cyst fluid (OCF).

Step 2

Use OvaCis® kit

This rapid immunochromatographic assay provides an initial screening result to discriminate benign from malignant ovarian cysts.

Step 3

Evaluate results

The results are available in 15 minutes.


If you're interested in OvaCis® and would like to know more or partner with us, let's chat.